Lung Cancer Genomic Testing Market: Technology Trends and Forecast 2035
The Lung Cancer Genomic Testing Market is expected to continue developing as genomic diagnostics become more closely integrated into cancer management. The market was valued at around USD 5.3 billion in 2024 according to WiseGuyReports' published market information, with projections indicating substantial growth toward 2035.
Several factors are contributing to this expansion. The rising prevalence of lung cancer is increasing the need for accurate diagnostic and molecular testing solutions. At the same time, advances in precision medicine are encouraging clinicians to use genomic information when evaluating treatment options.
Next-generation sequencing is expected to remain an important technology within the market. Its ability to assess multiple genetic markers can make it useful for comprehensive tumor profiling. PCR and FISH will also continue to serve important roles for detecting specific genetic abnormalities.
Liquid biopsy represents another promising opportunity. As blood-based genomic testing technologies improve, they may provide additional options for obtaining molecular information without relying exclusively on tissue samples.
The market is also supported by increasing research into targeted therapies and biomarker-driven treatment. Diagnostic companies, pharmaceutical organizations, hospitals, and research institutions are therefore expected to continue investing in genomic testing capabilities.
From a regional perspective, North America holds a leading position, while Europe and Asia-Pacific are expected to provide further opportunities. Expansion of healthcare infrastructure, increasing cancer research activity, and improving access to advanced diagnostics can support adoption across emerging markets.
Overall, innovation in sequencing, non-invasive testing, and personalized oncology is expected to remain central to the future development of lung cancer genomic testing.
Categories
- Artificial Intelligence (AI)
- Technology
- Business
- Education
- Science
- Lifestyle
- Healthcare
- Entertainment
- Politics
- Environment
- Travel
- Finance
- Automobile
- News
- Art
- Causes
- Crafts
- career
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
Read More
The Small Molecule Innovator CDMO Market is expanding as pharmaceutical and biotechnology companies increasingly outsource drug development and manufacturing activities to specialized contract development and manufacturing organizations. According to Market Research Future, the market was valued at USD 50.53 billion in 2024 and is projected to reach USD 80.04 billion by 2035, growing at a...
The converter modules market is witnessing steady growth as industries increasingly depend on efficient power conversion technologies for electronic devices, industrial equipment, communication systems, and transportation applications. Converter modules are electronic components that convert electrical power from one form to another, including direct current (DC) to direct current, direct...
The Unified Network Management Market is witnessing significant growth as organizations increasingly adopt integrated solutions to manage their network infrastructures. Unified network management refers to the consolidation of various network management functions into a single platform, allowing for more efficient monitoring, control, and optimization of network resources. As businesses become...
The metal recycling industry is entering a period of continued transformation as sustainability, technology, regulation, and industrial demand converge. Recycled metals are becoming increasingly valuable as manufacturers seek alternatives to virgin resources and governments encourage more efficient material management. According to MRFR, the Metal Recycling Market is projected to increase from...
Market Overview The antisense oligonucleotide therapeutics pipeline insight market is expanding as this gene-silencing technology continues to demonstrate therapeutic potential across rare genetic diseases and neurological disorders. Antisense oligonucleotides work by binding to specific RNA sequences to modulate protein production, offering a targeted approach to previously untreatable genetic...
